High Density Lipoproteins From Biological Understanding to Clinical Exploitation /

In this Handbook of Experimental Pharmacology on “High Density Lipoproteins – from biological understanding to clinical exploitation” contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regula...

Celý popis

Uloženo v:
Podrobná bibliografie
Korporativní autor: SpringerLink (Online service)
Další autoři: von Eckardstein, Arnold (Editor), Kardassis, Dimitris (Editor)
Médium: Elektronický zdroj E-kniha
Jazyk:angličtina
Vydáno: Cham : Springer International Publishing : Imprint: Springer, 2015.
Edice:Handbook of Experimental Pharmacology, 224
Témata:
On-line přístup:http://dx.doi.org/10.1007/978-3-319-09665-0
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

MARC

LEADER 00000nam a22000005i 4500
001 978-3-319-09665-0
003 DE-He213
005 20180131132527.0
007 cr nn 008mamaa
008 141218s2015 gw | s |||| 0|eng d
020 |a 9783319096650  |9 978-3-319-09665-0 
024 7 |a 10.1007/978-3-319-09665-0  |2 doi 
050 4 |a RM1-950 
072 7 |a MMG  |2 bicssc 
072 7 |a MED071000  |2 bisacsh 
082 0 4 |a 615  |2 23 
245 1 0 |a High Density Lipoproteins  |h [electronic resource] :  |b From Biological Understanding to Clinical Exploitation /  |c edited by Arnold von Eckardstein, Dimitris Kardassis. 
264 1 |a Cham :  |b Springer International Publishing :  |b Imprint: Springer,  |c 2015. 
300 |a XIII, 694 p. 40 illus., 37 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Handbook of Experimental Pharmacology,  |x 0171-2004 ;  |v 224 
505 0 |a Preface -- Part 1. Physiology of HDL -- Part 2. Pathology of HDL -- Part 3. Possible Indications and Target Mechanisms of HDL Therapy -- Part 4. Treatments for Dyslipidemias and Dysfunction of HDL. 
506 0 |a Open Access 
520 |a In this Handbook of Experimental Pharmacology on “High Density Lipoproteins – from biological understanding to clinical exploitation” contributing authors (members of COST Action BM0904/HDLnet) summarize in more than 20 chapters our current knowledge on the structure, function, metabolism and regulation of HDL in health and several diseases as well as the status of past and ongoing attempts of therapeutic exploitation. The book is of interest to researchers in academia and industry focusing on lipoprotein metabolism, cardiovascular diseases and immunology as well as clinical pharmacologists, cardiologists, diabetologists, nephrologists and other clinicians interested in metabolic or inflammatory diseases. 
650 0 |a Medicine. 
650 0 |a Human physiology. 
650 0 |a Immunology. 
650 0 |a Molecular biology. 
650 0 |a Pharmacology. 
650 0 |a Cell biology. 
650 1 4 |a Biomedicine. 
650 2 4 |a Pharmacology/Toxicology. 
650 2 4 |a Molecular Medicine. 
650 2 4 |a Human Physiology. 
650 2 4 |a Immunology. 
650 2 4 |a Cell Biology. 
700 1 |a von Eckardstein, Arnold.  |e editor. 
700 1 |a Kardassis, Dimitris.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783319096643 
830 0 |a Handbook of Experimental Pharmacology,  |x 0171-2004 ;  |v 224 
856 4 0 |u http://dx.doi.org/10.1007/978-3-319-09665-0 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642) 
999 |c 188837  |d 188837